Related Experiment Videos
Alessandro Tedesco1, Marzia Bonfanti1, Asia Barugolo1
1PharmaLex Italy SpA, Milano - Italy.
Global & Regional Health Technology Assessment
|May 22, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027.
Health economics review·2025
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?
Journal of market access & health policy·2025
Integrating MCDA and economic evaluation into a rule-based framework for hospital-level health technology assessment.
Global & regional health technology assessment·2026
Burden of primary biliary cholangitis on the Italian National Health Service: retrospective analysis from an administrative database.
Global & regional health technology assessment·2026
Pharmacoeconomic analysis of switch to faricimab for neovascular age-related macular degeneration in real clinical practice.
Global & regional health technology assessment·2026
Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics.
Global & regional health technology assessment·2026
Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry.
Global & regional health technology assessment·2026
Procedural activity and dynamics of the new Italian Scientific and Economic Committee (CSE): a one-year observational analysis.
Global & regional health technology assessment·2026